RISK21 Advisors

The RISK21 v2.0 public-private Scientific Advisory Board (SAB) and ad-hoc advisors is comprised of leading experts in risk assessment and related disciplines. This Advisory team is tasked with developing a strategic plan to support the overall program goals. 

 

Science Advisory Board

  • Michelle Embry (HESI)
  • Jon Arnot (ARC)
  • Juliana Braz (Brazilian Health Regulatory Agency - ANVISA)
  • Sandrine Deglin (HESI)
  • Suzanne Hartigan (American Chemistry Council)
  • Haitian Lu (Syngenta)
  • Camila Oueiroz Moreira (Brazilian Health Regulatory Agency - ANVISA)
  • Angelo Moretto  (U of Milan)
  • Eliana Munarriz (U of Buenos Aires)
  • Claire Terry (Corteva)
  • Maria Trainer (Australian Pesticides and Veterinary Medicines Authority)
  • Marcelo Wolansky (U of Buenos Aires)
  • Doug Wolf (Syngenta)
  • Steven Zou (ExxonMobil)

Ad-hoc Advisors

  • Tara Barton-McClaren (Health Canada)
  • Gino Scarano (USEPA)
  • Zuzana Kloslova (ECHA)
  • Angelika Zidek (Health Canada)